Metabolomics as an accelerator of 5P medicine |
Part 1: Polyamine acetylation as a driver of immunotherapy response
All posts to the category
Blog
Biognosys Group at AZ Metabolomics & T32 Symposium
This year’s Arizona Metabolomics & T32 Symposium was hosted by Dr. Haiwei Gu and Dr. Corrie Whisner at Arizona State University in Phoenix, AZ. This one-day event highlighted a variety of emerging research topics and applications in the field of metabolomics, systems biology, and health.
Dimethylglycine – from cold war hype to hot topic
Dimethylglycine is a molecular entry point into individualized, systems-oriented healthcare. Altered DMG levels have been linked to cardiometabolic risk and conditions such as myocardial infarction, diabetes, and metabolic dysfunction-associated liver disease.
Fructose – sweet molecule with systemic impact
Fructose is a simple sugar found in fruits and honey, but also added to many processed foods. Unlike glucose, it is mainly metabolized in the liver, and excessive intake can contribute to metabolic and inflammatory health issues.
How metabolomics is improving healthcare – 6 must-read studies from 2025
biocrates’ standardized metabolomics empowers global research. Here is a selection of how our community of users has translated molecular fingerprints into insights for 5P medicine in 2025.